Follow Us:
Wednesday, July 06, 2022

Dr Reddy's


Sputnik V vaccine for Covid-19 to be priced at Rs 995 in India; first dose administered in Hyderabad

May 14, 2021 12:59 pm

Dr Reddy's administered the first shot of Russia's Sputnik V vaccine for Covid-19 in Hyderabad on Friday.

Dr Reddy's ADRs list on NSE International Exchange

December 09, 2020 1:42 pm

The secondary listing of Dr Reddy's American Depository Receipts (ADRs) at NSE IFSC would provide global investors an additional venue to transact in their ADRs, the National Stock Exchange (NSE) said in a statement on Wednesday.

Dr Reddy's Q2 profit falls 30% at Rs 762 crore

October 28, 2020 3:16 pm

On October 22, the company experienced an information security incident and consequently isolated the impacted IT services. This incident involved a ransom-ware attack, Dr Reddy's said.

Dr Reddy’s isolates data centre services after cyber attack

October 23, 2020 11:36 am

“In the wake of a detected cyber-attack, we have isolated all data centre services to take required preventive actions,” Dr Reddy's told the Bombay Stock Exchange on Thursday.

Dr Reddy's shares extend rally; zoom nearly 10%

September 18, 2020 1:59 pm

Continuing its rally for the fourth consecutive day, Dr Reddy's Laboratories stock gained 9.86 per cent to Rs 5,302.85 -- its record high level -- on the BSE. At the NSE, it zoomed 9.79 per cent to an all-time high of Rs 5,300.

Dr Reddy’s inks deal to distribute 100 mn doses of Sputnik V

September 17, 2020 4:41 pm

This is the first concrete development on Sputnik V after the Indian government confirmed it was in discussions to take forward the testing and manufacture of the candidate, which Russia approved for public use last month.

COVID-19 related uncertainties may continue in current fiscal: Dr Reddy's

July 06, 2020 5:24 pm

The stockpiling of OTC products is expected to continue in the short-term, and result in demand surges for those drugs.

Dr Reddy's Laboratories posts Q3 loss at Rs 570 crore

January 27, 2020 12:54 pm

The consolidated revenues of the company in the October-December period increased to Rs 4,383.8 crore, over Rs 3,850 crore in the year-ago period, Dr Reddy's Laboratories said in a filing to BSE.

Chinese strategy: Dr Reddy's outsources part manufacturing to local parties

November 21, 2019 4:31 pm

The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's

Dr Reddy’s to sell Hyderabad API unit to Therapiva

October 16, 2018 4:31 am

The sale includes all related fixed assets which includes land and building, current assets, current liabilities and its employees, the company said in a statement.